Diane K. Luci

1.4k total citations
19 papers, 940 citations indexed

About

Diane K. Luci is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Diane K. Luci has authored 19 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Surgery. Recurrent topics in Diane K. Luci's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers), Chemical Synthesis and Analysis (3 papers) and Diet, Metabolism, and Disease (3 papers). Diane K. Luci is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers), Chemical Synthesis and Analysis (3 papers) and Diet, Metabolism, and Disease (3 papers). Diane K. Luci collaborates with scholars based in United States, Sweden and Bulgaria. Diane K. Luci's co-authors include David J. Maloney, Anton Simeonov, Ajit Jadhav, Thomas S. Dexheimer, Hongmao Sun, Andrew S. Rosenthal, Liang Qin, Zhihao Zhuang, Junjun Chen and Michael Holinstat and has published in prestigious journals such as Nature Communications, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Diane K. Luci

19 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane K. Luci United States 13 488 182 159 95 94 19 940
Christina Lamers Germany 16 494 1.0× 175 1.0× 193 1.2× 22 0.2× 48 0.5× 30 961
David N. Deaton United States 23 549 1.1× 303 1.7× 373 2.3× 55 0.6× 133 1.4× 48 1.2k
Vanessa Desplat France 20 323 0.7× 683 3.8× 103 0.6× 60 0.6× 40 0.4× 52 1.2k
Frédéric Massé Canada 18 749 1.5× 361 2.0× 157 1.0× 42 0.4× 281 3.0× 22 1.4k
Yi-Min Liu Taiwan 16 535 1.1× 211 1.2× 175 1.1× 40 0.4× 143 1.5× 22 996
Manoj K. Ramjee United Kingdom 15 412 0.8× 139 0.8× 52 0.3× 67 0.7× 40 0.4× 23 931
Jun Ohsumi Japan 18 535 1.1× 111 0.6× 311 2.0× 44 0.5× 151 1.6× 31 1.2k
C. H. Baker United States 13 751 1.5× 88 0.5× 172 1.1× 41 0.4× 84 0.9× 37 1.1k
Xiaojuan Xiao China 19 454 0.9× 134 0.7× 224 1.4× 32 0.3× 59 0.6× 55 1.0k
Yuan Yao United States 24 916 1.9× 154 0.8× 112 0.7× 23 0.2× 81 0.9× 50 1.5k

Countries citing papers authored by Diane K. Luci

Since Specialization
Citations

This map shows the geographic impact of Diane K. Luci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane K. Luci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane K. Luci more than expected).

Fields of papers citing papers by Diane K. Luci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane K. Luci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane K. Luci. The network helps show where Diane K. Luci may publish in the future.

Co-authorship network of co-authors of Diane K. Luci

This figure shows the co-authorship network connecting the top 25 collaborators of Diane K. Luci. A scholar is included among the top collaborators of Diane K. Luci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane K. Luci. Diane K. Luci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Stafford, William C., Xiaoxiao Peng, Maria Hägg Olofsson, et al.. (2018). Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Science Translational Medicine. 10(428). 164 indexed citations
2.
Ma, Kaiwen, An Xiao, So Hyun Park, et al.. (2017). 12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2789–2797. 22 indexed citations
3.
Adili, Reheman, Benjamin E. Tourdot, Jennifer Yeung, et al.. (2017). First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis. Arteriosclerosis Thrombosis and Vascular Biology. 37(10). 1828–1839. 82 indexed citations
4.
Dexheimer, Thomas S., Andrew S. Rosenthal, Diane K. Luci, et al.. (2014). Synthesis and Structure–Activity Relationship Studies ofN-Benzyl-2-phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer. Journal of Medicinal Chemistry. 57(19). 8099–8110. 52 indexed citations
5.
Luci, Diane K., Adam Yasgar, Netra Joshi, et al.. (2014). Synthesis and Structure–Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase. Journal of Medicinal Chemistry. 57(2). 495–506. 65 indexed citations
6.
Qin, Liang, Thomas S. Dexheimer, Andrew S. Rosenthal, et al.. (2014). A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses. Nature Chemical Biology. 10(4). 298–304. 202 indexed citations
7.
Luci, Diane K., Adam Yasgar, Netra Joshi, et al.. (2014). Discovery of ML355, a Potent and Selective Inhibitor of Human 12-Lipoxygenase. 17 indexed citations
8.
Yeung, Jennifer, Benjamin E. Tourdot, Jin Ren, et al.. (2014). Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation. Blood. 124(14). 2271–2279. 68 indexed citations
9.
Srinivasan, P., Adam Yasgar, Diane K. Luci, et al.. (2013). Disrupting malaria parasite AMA1–RON2 interaction with a small molecule prevents erythrocyte invasion. Nature Communications. 4(1). 2261–2261. 86 indexed citations
10.
Luci, Diane K., Wendy Lea, Rafaela Salgado Ferreira, et al.. (2013). Reversible and non-covalent benzimidazole-based in vivo lead for Chagas disease. Europe PMC (PubMed Central). 3 indexed citations
11.
Maryanoff, Bruce E., John O’Neill, David F. McComsey, et al.. (2012). Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket. Bioorganic & Medicinal Chemistry Letters. 22(16). 5326–5329. 9 indexed citations
12.
Maryanoff, Bruce E., John O’Neill, David F. McComsey, et al.. (2011). Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. ACS Medicinal Chemistry Letters. 2(7). 538–543. 28 indexed citations
13.
Luci, Diane K., Edward C. Lawson, Shyamali Ghosh, et al.. (2009). Generation of novel, potent urotensin-II receptor antagonists by alkylation–cyclization of isoindolinone C3-carbanions. Tetrahedron Letters. 50(35). 4958–4961. 30 indexed citations
14.
Lawson, Edward C., Diane K. Luci, Shyamali Ghosh, et al.. (2009). Nonpeptide Urotensin-II Receptor Antagonists: A New Ligand Class Based on Piperazino-Phthalimide and Piperazino-Isoindolinone Subunits. Journal of Medicinal Chemistry. 52(23). 7432–7445. 69 indexed citations
15.
Luci, Diane K., Shyamali Ghosh, Charles E. Smith, et al.. (2007). Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: Synthesis, SAR, and in vivo assessment. Bioorganic & Medicinal Chemistry Letters. 17(23). 6489–6492. 14 indexed citations
16.
Kinney, William A., Diane K. Luci, Rosemary J. Santulli, et al.. (2004). A Concise Synthesis of an Indenopyrrolidine-based Dual avb3/avb5 Integrin Antagonist. Heterocycles. 62(1). 543–543. 9 indexed citations
17.
Lawson, Edward C., William A. Kinney, Michael J. Costanzo, et al.. (2004). Structure-Function Study of Quinazolinone-Based Vitronectin Receptor (αVβ3) Antagonists: Computer-Assisted Analysis of Ligand-Receptor Interactions. Letters in Drug Design & Discovery. 1(1). 14–18. 8 indexed citations
18.
Lawson, Edward C., William A. Kinney, Diane K. Luci, et al.. (2002). The Heck reaction with unprotected allylic amidines and guanidines. Tetrahedron Letters. 43(11). 1951–1953. 5 indexed citations
19.
Wipf, Peter, et al.. (2000). Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors. Biotechnology and Bioengineering. 71(1). 58–70. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Lamers Breakdown of academic impact, for papers by David N. Deaton Breakdown of academic impact, for papers by Vanessa Desplat Breakdown of academic impact, for papers by Frédéric Massé Breakdown of academic impact, for papers by Yi-Min Liu Breakdown of academic impact, for papers by Manoj K. Ramjee Breakdown of academic impact, for papers by Jun Ohsumi Breakdown of academic impact, for papers by C. H. Baker Breakdown of academic impact, for papers by Xiaojuan Xiao Breakdown of academic impact, for papers by Yuan Yao
Rankless by CCL
2026